Messages in brief

An overview of information by BASG to the novel Corona virus SARS-CoV-2 and the COVID-19 disease as well as links to websites with further information.

The registry lists in a new form - with search and filter options - those SARS-CoV-2 rapid antigen tests that can be placed on the Austrian market for self-testing.

Up-to-date information from the June 21-24 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

Up-to-date information from the May 17-20 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

On May 28, 2021, the use "for active immunization of individuals 12 years of age and older" was extended by the EMA.

As of 22.5.2021, the function "Withdrawal according to §23 AMG" will be available in the area "Overview Medicinal Products".

The EMA adopted the new recommendations for the composition of seasonal influenza vaccines for the season 2021/2022 (published 30 March 2021)

This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.

National Vaccination Committee recommends extended dosage intervals for mRNA vaccines